“FDA recommends sharing your protocol and statistical analysis plan before the real-world study is conducted… to ensure the analysis wasn’t cherry-picked.”
MD
Meryl Dersarkissian
FDA Watch ·
Marianne Cunnington · FDA Watch · The Rise of Real-World Evidence in Regulatory Strategy, Part 4: RWE in Postmarketing Studies
Audio streams from the publisher’s own feed. Verbatim does not host or copy it.
perform a structured feasibility assessment to determine if a real-world data source is fit-for-purpose for a specific research question before starting a post-marketing study
“FDA recommends sharing your protocol and statistical analysis plan before the real-world study is conducted… to ensure the analysis wasn’t cherry-picked.”
“I obviously come into my podcast with my guests prepared, research their background, you know, their digital footprint, what's going on, structured questions.”
“The AI content has performed way better than the real world content and has achieved 10% higher conversion rate”
“The data must be accurate, complete, and traceable back to the source to allow us to do source data verification.”
The strongest new moments on your topics, in the speakers' own words. Free for three topics.
No card. No password. One-click unsubscribe.
Pro watches up to 25 names or phrases and emails you the morning after they are said.
See Pro, $29 a monthVerbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.